These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter? Kanematsu M Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455 [No Abstract] [Full Text] [Related]
105. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent]. Kitoh Y Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090 [No Abstract] [Full Text] [Related]
110. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents. Ichikawa T Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734 [TBL] [Abstract][Full Text] [Related]
112. Hepatocellular carcinoma and other hepatic malignancies: MR imaging. Roth CG; Mitchell DG Radiol Clin North Am; 2014 Jul; 52(4):683-707. PubMed ID: 24889167 [TBL] [Abstract][Full Text] [Related]
113. Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. Shimofusa R; Ueda T; Kishimoto T; Nakajima M; Yoshikawa M; Kondo F; Ito H J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):583-9. PubMed ID: 19809781 [TBL] [Abstract][Full Text] [Related]